Abstract: HSCI entry. MiniMax becomes a strong HSCI candidate for June 2026 with MV12 of HKD 225bn. HS TECH entry. We expect MiniMax to enter HS TECH at the May 2026 review. HSI barrier. The FY25 net loss will likely fail it for the immediate HSI review.
MINIMAX-WP, Kuaishou, CHINA RESOURCES LAND, AIA, CHINA HONGQIAO, SENSETIME, KNOWLEDGE ATLAS, Kingdee, MIDEA, HANSOH PHARMACEUTICAL, CATL, KINGSOFT, BEONE MEDICINES, LENOVO, ALIBABA
Interested in the full report? Get in touch with our team.